Inmed Pharmaceuticals Inc Stock Return On Equity
| MWG0 Stock | 4.17 0.23 5.84% |
INMED PHARMACEUTICALS INC fundamentals help investors to digest information that contributes to INMED PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of INMED Stock. The fundamental analysis module provides a way to measure INMED PHARMACEUTICALS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INMED PHARMACEUTICALS stock.
INMED |
INMED PHARMACEUTICALS INC Company Return On Equity Analysis
INMED PHARMACEUTICALS's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Based on the latest financial disclosure, INMED PHARMACEUTICALS INC has a Return On Equity of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Return On Equity (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
About INMED PHARMACEUTICALS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INMED PHARMACEUTICALS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INMED PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INMED PHARMACEUTICALS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.